Human (cid:1) Defensin in HIV-Exposed But Uninfected Individuals

: Human (cid:1) defensins 1, 2, and 3 are produced by CD8 + T cells of HIV-infected long-term nonprogressors and have an antiviral activity. (cid:1) Defensinswereexaminedinperipheralbloodmononuclear cells (PBMCs), cervical-vaginal mononuclear cells (CVMCs), and cervical biopsies of 9 HIV-1-exposed but uninfected women (ESNs), 10 HIV-infected patients (HIV), and 13 low-risk healthy controls (HCs). Results showed that, whereas (cid:1) defensin production and (cid:1) defensin-expressing CD8 lymphocytes were comparable in ESNs and HIV patients, constitutive (cid:1) defensin production by peripheral CD8 and CVMCs was augmented in ESNs compared with HCs ( P = 0.001 and P = 0.058, respectively); (cid:1) defensin mRNA was increased in PBMCs of ESNs; unstimulated, (cid:1) defensin-expressing peripheral and mucosal CD8 lymphocytes were 10-fold higher in ESNs compared with HCs ( P = 0.003 and P = 0.01, respectively); and (cid:1) defensin mRNA and (cid:1) defensin-expressing cells were augmented in cervical biopsies of ESN compared with HCs (mRNA: P = 0.03). The differences were reduced upon in vitro mitogen stimulation. A robust constitutive production of (cid:1) defensin is seen in HIV-exposed uninfected individuals; these peptides could have a role in the potentially protective immune response that characterizes ESNs.

[1]  D. Scott‐Algara,et al.  CD4 cell and CD8 cell-mediated resistance to HIV-1 infection in exposed uninfected intravascular drug users in Vietnam , 2003, AIDS.

[2]  John P. Moore.  Faculty Opinions recommendation of CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition. , 2003 .

[3]  Annapurna Vyakarnam,et al.  Presence of HIV-1 Gag-Specific IFN-γ+IL-2+ and CD28+IL-2+ CD4 T Cell Responses Is Associated with Nonprogression in HIV-1 Infection1 , 2002, The Journal of Immunology.

[4]  C. Hallahan,et al.  HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors , 2002, Nature Immunology.

[5]  B. Gazzard,et al.  A Balanced Type 1/Type 2 Response Is Associated with Long-Term Nonprogressive Human Immunodeficiency Virus Type 1 Infection , 2002, Journal of Virology.

[6]  J. Levy,et al.  Relationship of CD8(+) T cell noncytotoxic anti-HIV response to CD4(+) T cell number in untreated asymptomatic HIV-infected individuals. , 2002, Blood.

[7]  E. Dalmasso,et al.  Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. , 2002, Science.

[8]  K. Fellermann,et al.  Defensins – innate immunity at the epithelial frontier , 2001, European journal of gastroenterology & hepatology.

[9]  R. Brookmeyer,et al.  Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda , 2001, The Lancet.

[10]  S. Steinberg,et al.  Generation of alloantigen-stimulated anti-human immunodeficiency virus activity is associated with HLA-A*02 expression. , 2001, The Journal of infectious diseases.

[11]  M. Luscher,et al.  Sequence and peptide-binding motif for a variant of HLA-A*0214 (A*02142) in an HIV-1-resistant individual from the Nairobi Sex Worker cohort , 2001, Immunogenetics.

[12]  K. Conant,et al.  The role of chemokines in human immunodeficiency virus infection , 2000, Immunological reviews.

[13]  S. Rowland-Jones,et al.  Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. , 2000, The Journal of infectious diseases.

[14]  K. Rabe,et al.  Defensins: key players or bystanders in infection, injury, and repair in the lung? , 1999, The Journal of allergy and clinical immunology.

[15]  D. Cooper,et al.  CD8+ anti-human immunodeficiency virus suppressor activity (CASA) in response to antiretroviral therapy: loss of CASA is associated with loss of viremia. , 1999, The Journal of infectious diseases.

[16]  P. Vernazza,et al.  Sexual transmission of HIV: infectiousness and prevention. , 1999, AIDS.

[17]  J. Skurnick,et al.  Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Kaul,et al.  HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers. , 1999, AIDS.

[19]  J. Phair,et al.  A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation , 1998, Nature Medicine.

[20]  Luc Montagnier,et al.  HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene , 1998, The Lancet.

[21]  M. Robb,et al.  Epidemiologic and Biologic Characterization of a Cohort of Human Immunodeficiency Virus Type 1 Highly Exposed, Persistently Seronegative Female Sex Workers in Northern Thailand , 1998 .

[22]  R. Koup,et al.  Genetic and immunological host factors associated with susceptibility to HIV-1 infection. , 1998, AIDS.

[23]  M. Clerici,et al.  HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals , 1997, Nature Medicine.

[24]  C. Janeway,et al.  Innate Immunity: The Virtues of a Nonclonal System of Recognition , 1997, Cell.

[25]  Richard A Koup,et al.  Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.

[26]  J. Levy,et al.  Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. , 1996, Immunology today.

[27]  Steven M. Wolinsky,et al.  Relative resistance to HIV–1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high–risk sexual exposures , 1996, Nature Medicine.

[28]  M. Clerici,et al.  Protective immunity against HIV infection: has nature done the experiment for us? , 1996, Immunology today.

[29]  R. Ahmed,et al.  Immunity to infection. , 1998, Current opinion in immunology.

[30]  S. Rowland-Jones,et al.  Immune responses in HIV-exposed seronegatives: have they repelled the virus? , 1995, Current opinion in immunology.

[31]  J. Berzofsky,et al.  ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. , 1995, The Journal of clinical investigation.

[32]  J. Berzofsky,et al.  HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood. , 1994, JAMA.

[33]  J. Berzofsky,et al.  Cellular immune factors associated with mother‐to-infant transmission of HIV , 1993, AIDS.

[34]  T. Ganz,et al.  Isolation and characterization of human defensin cDNA clones. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[35]  T. Ganz,et al.  DEFENSINS: NATURAL PEPTIDE ANTIBIOTICS IN HUMAN NEUTROPHILS , 1986 .